Pacific Biosciences of California, Inc. (PACB) — Stock Score Summary

Pacific Biosciences of California, Inc. (PACB) has a MoatMap StockRank of 3/100 based on Quality (21/100), Value (34/100), and Momentum (20/100) factor scores. The current signal is STRONG SELL. Pacific Biosciences of California is a leader in long-read gene sequencing. While its technology is highly regarded, the company has historically struggled with profitability, high cash burn, and intense competition from Illumina. It fails the Terry Smith lens of being an asset-light, high-ROIC compounder with pricing power.

Pacific Biosciences of California, Inc. develops and markets advanced DNA sequencing systems utilizing its proprietary Single Molecule, Real-Time (SMRT) technology. The company holds a strong position in the long-read sequencing market, providing high-fidelity data essential for complex genomic research and clinical applications. Its innovative technology offers a competitive moat by enabling more comprehensive analysis compared to traditional short-read methods.

Key Financial Metrics

Price$1.37
Market Cap$457M
P/E (Forward)-4.11
Price/Book203.75
Return on Equity-273.6%
Return on Invested Capital-75.8%
Debt/Equity29855.79
Gross Margin38.3%
Operating Margin-102.9%
Revenue Growth0.1%
Free Cash Flow$-48M

Pacific Biosciences of California, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Pacific Biosciences of California, Inc.’s (PACB) StockRank?
MoatMap’s StockRank for Pacific Biosciences of California, Inc. (PACB) is 3/100, with a Strong Sell signal. It is a composite of Quality (21), Value (34), and Momentum (20) factor ranks across MoatMap’s 19,000+ stock universe.
Does Pacific Biosciences of California, Inc. have an economic moat?
Pacific Biosciences of California, Inc. (PACB) has a Quality factor score of 21/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Pacific Biosciences of California, Inc. a buy, hold, or sell?
MoatMap’s current signal for Pacific Biosciences of California, Inc. (PACB) is Strong Sell, based on a StockRank of 3/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Pacific Biosciences of California, Inc. in?
Pacific Biosciences of California, Inc. (PACB) operates in the Healthcare sector, specifically the Medical Devices industry (United States).
Browse all ranked stocksPACB deep dive reportAI ChampionsHow we score stocksSense-check another stock